Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesAnemia, AplasticTransplantation ConditioningHematopoietic Stem Cell TransplantationLeukemiaLiver TransplantationTransplantation ChimeraTissue DonorsGraft SurvivalBusulfanBone Marrow PurgingHistocompatibility TestingHematopoietic Stem CellsHistocompatibilityCyclophosphamideAntineoplastic AgentsTransplantation, IsogeneicBone Marrow DiseasesKidney TransplantationCombined Modality TherapyRecurrenceHematopoiesisNeoplasmsMice, Inbred C57BLRadiation ChimeraTime FactorsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveTreatment OutcomeLeukemia, Myeloid, AcuteBone Marrow ExaminationImmunosuppressive AgentsRemission InductionHematologic NeoplasmsGraft RejectionPrecursor Cell Lymphoblastic Leukemia-LymphomaBone RemodelingHepatic Veno-Occlusive DiseaseBone Marrow NeoplasmsSurvival AnalysisTransplantation ImmunologyLeukemia, MyeloidGraft vs Host ReactionRetrospective StudiesImmunosuppressionLymphoma, Non-HodgkinStem Cell TransplantationLymphocyte DepletionLeukocyte TransfusionAcute DiseaseHeart TransplantationT-LymphocytesAntineoplastic Combined Chemotherapy ProtocolsSevere Combined ImmunodeficiencyColony-Forming Units AssayChimeraHLA AntigensMyelodysplastic SyndromesFollow-Up StudiesSurvival RateLung TransplantationActuarial AnalysisHematologic DiseasesBone DensityCyclosporineLymphocyte TransfusionDisease-Free SurvivalNuclear FamilyCell DifferentiationMice, Inbred BALB CCarmustineOrgan TransplantationPrognosisFlow CytometryPancytopeniaGraft vs Tumor EffectLeukocyte CountCytarabineGraft vs Leukemia EffectCytomegalovirus InfectionsSpleenGranulocyte Colony-Stimulating FactorEtoposideBone ResorptionMelphalanLymphomaCells, CulturedAntibodies, MonoclonalMultiple MyelomaBone NeoplasmsFatal OutcomeProspective StudiesDrug Resistance, NeoplasmMice, Knockout